Targets & Cell Types in Immuno-Oncology
Europe Edition 2023 | November 14 - 15 | Booth #22 - Berlin, Germany
Join us BOOTH #22 for Targets & Cell Types in Immuno-Oncology | Europe 2023!
With emerging targets and drug candidates in immuno-oncology, researchers and industry leaders from pharmaceutical and biotech organizations will be show casing innovative approaches and methods for target identification & validation.
➡️ What to expect from the event?
- Hear from and meet with the key innovators in novel targets & cell types in immuno-oncology.
- Discuss the latest innovations in novel targets & target validation in immuno-oncology.
- Discover collaborative solutions to novel cell types to develop effective IO therapies. Delve into case studies in the utilization of various cellular therapies such as TILs, suppressor & myeloid cells, preclinical tumor models and bispecific antibodies activating the immune system.
- Join a series of roundtables, panel discussions and workshops pertaining to the latest immuno-oncology research & development.
➡️ Why should you meet us during the event?
Cytosurge offers a unique capability to manipulate individual cells with the help of the FluidFM technology, including the FluidFM OMNIUM platform and the CellEDIT CRISPR Cell Line Engineering Service.
This cutting-edge technology enables the direct injection of CRISPR reagents into the cell's nucleus for precision gene engineering, and the gentle cytoplasmic extraction - biopsy for temporal single-cell profiling, across a broad range of cell types and applications, while ensuring that cell viability is maintained.
Such solutions can help to:
✅ Deepen your understanding of tumor-immune dynamics.
✅ Accelerate drug discovery processes
Aid the development and optimization of novel immuno-oncology therapies.
📨 Feel free to drop us a line at email@example.com if you wish to discuss further or to book a 1:1 meeting during the conference!
More information about the event available here.